Belenus Champion Hospital Unveils "GI Oncology Clinic" With Free Second Opinion OPD Services

Belenus Champion Hospital takes a giant leap in GI cancer care with the inauguration of the "GI Oncology Clinic," a specialized center devoted to Gastrointestinal Oncology. The clinic, located in the heart of Bengaluru, is equipped with cutting-edge technology and managed by the distinguished Head of Department, Dr. Vikram J Rao, a renowned Senior Consultant in the field.

The launch event witnessed the presence of esteemed guests, including Shri Nadoja Dr. Mahesh Joshi, President, Kannada Sahitya Parishat; Shri Vishal Jain, CEO of Zerodha Asset Management Pvt Ltd; Shri Ananth Hejamady Shanker Rao, Management Consultant at Wipro; Dr. Kishore, Co-founder of Belenus Hospital; Dr. Manjunath, Founder of Belenus Hospital; and Dr. Shashidhar, CEO of Belenus Hospital.

Dr. Vikram J Rao, Head of the GI Oncology Clinic, expressed his enthusiasm, stating, "The GI Oncology Clinic at Belenus Champion Hospital is a testament to our commitment to providing comprehensive and advanced cancer care. We aim to be a beacon of hope for patients dealing with gastrointestinal cancers by combining expertise, technology, and compassionate care."

Shri Nadoja Dr. Mahesh Joshi emphasized the importance of such specialized healthcare services in Bengaluru, stating, "The GI Oncology Clinic is a commendable initiative that brings world-class cancer care to our city. It reflects the hospital's dedication to the well-being of the community."

Shri Vishal Jain, CEO of Zerodha Asset Management Pvt Ltd, highlighted the positive impact of corporate support in healthcare, saying, "Belenus Champion Hospital's focus on specialized clinics like GI Oncology is a welcome step. Corporate partnerships in healthcare can significantly contribute to advancing medical services in our society."

Shri Ananth Hejamady Shanker Rao, Management Consultant at Wipro, shared, "I applaud the hospital's efforts in establishing a one stop center in the form of GI Oncology Clinic, a much-needed addition to Bengaluru's healthcare landscape. It aligns with the city's growth in becoming a hub for advanced medical services."

Dr. Kishore, Co-founder of Belenus Hospital, expressed his pride in the hospital's continued commitment to excellence, saying, "The GI Oncology Clinic reinforces our vision to provide top-notch healthcare. We believe in evolving with the ever-changing medical landscape to better serve our patients."

Dr. Manjunath, Founder of Belenus Hospital, remarked, "The launch of the GI Oncology Clinic is a significant achievement for Belenus Champion Hospital. It reflects our dedication to addressing the specific healthcare needs of our community."

Dr. Shashidhar, CEO of Belenus Hospital, concluded, "The GI Oncology Clinic is a cornerstone in our mission to offer comprehensive and compassionate healthcare. We are proud to extend our services to those in need and contribute to the fight against gastrointestinal cancers."

The GI Oncology Clinic launch event also marks the initiation of Free Second Opinion OPD services, allowing patients to access expert advice on their medical condition aiding in important decision makings regarding treatment options which will be tailor made for each one.

For appointments and more information, contact: 080 - 6936 6936

Join us at Belenus Champion Hospital's GI Oncology Clinic as we embark on a journey to redefine cancer care in Bengaluru.

Samsung Announces Its Grand Republic Day Sale With Mega Offers On Samsung.com, Samsung Shop App And Samsung Exclusive Stores

Highlights

Up to 57% off on select Galaxy smartphones and up to 48% off on select models of Samsung premium and lifestyle TVs

Samsung Galaxy Tablets, Accessories and Wearables will be available at up to 50% off

Up to 52% off on select models of refrigerators with exchange benefits of up to INR 15125

Up to 22.5% cashback with leading cards (Up to INR 25000)

Bengaluru, January 20, 2024: Samsung, India’s largest consumer electronics brand, has launched its Grand Republic Sale with bumper offers and cashback on a variety of Samsung products such as Galaxy smartphones, laptops, tablets, wearables, Samsung TVs, and other digital appliances. These offers will be available on Samsung.com, Samsung Shop App, and Samsung Exclusive Stores. Consumers will get up to 22.5% cashback (Up to INR 25000) on HDFC Bank, ICICI Bank, Axis Bank and other leading Bank Debit and Credit Cards.

During the bonanza sale, consumers buying select models of Galaxy A series, M series, F series, S series and flagship models of Galaxy Z Series can get up to 57% off. Consumers will also get amazing offers on pre-booking the latest Galaxy S24 series smartphones. Under the Grand Republic Day Sale, consumers can avail Galaxy S23 for just INR 54999. Those purchasing Galaxy laptops such as Galaxy Book Go, Galaxy Book3, and Galaxy Book 3 Pro, can avail up to 46% off and consumers buying select models of Galaxy tablets, wearables and accessories can get up to 50% off.

Consumers purchasing premium and lifestyle models of Samsung televisions can avail up to 48% off with an additional exchange benefit of up to INR 15250. Consumers buying select models of Neo QLED and QLED will also get an assured special gift from either of the following - Galaxy S23 Ultra worth INR 124990 or a 50" Serif TV worth INR 69990, or a Soundbar worth INR 38990 (Q700C / C450).

During the sale, consumers buying Samsung digital appliances such as refrigerators will get up to 52% off, on select models of refrigerators. Consumers can also get exchange benefits up to INR 15125 on select models.

On purchase of microwaves such as 28 litre SlimFry Microwave and 32 litre Wi-Fi enabled Bespoke Microwave, consumers can avail up to 45% off. Consumers purchasing select models of EcobubbleTM range of fully automatic washing machines will get up to 49% off with an extra benefit of INR 3000 as an upgrade bonus.

ELGi Harnesses 63 Years Of Compressed Air Excellence To Fly The Indian Flag High Ahead Of 75th Republic Day

* Technology innovation and a spirit of resilience converge to ensure the Indian national flag flies majestically in low-wind conditions.

Elgi Equipments (BSE: 522074 NSE: ELGIEQUIP), one of the world’s leading air compressor manufacturers, has successfully developed a technology solution capable of delivering air at adequate volume and pressure to sustain the flying of a flag during periods of low wind speed.

When a national flag flies, it evokes a lot of emotion. However, sometimes, when the wind is less, flags droop. "Project Tiranga" at ELGi, conceptualized to ensure that the national flag flew high, was initiated with an enterprise-wide innovation challenge that yielded promising concepts, each leveraging ELGi’s expertise in compressed air technology. A team of ELGians from operations and technology demonstrated unwavering dedication to the mission, and a breakthrough solution finally emerged after rigorous testing and validation, reflecting the resilience and expertise ingrained in ELGi's ethos. The solution comprised a mechanical system that lifted the flag using blowers, a swivel mechanism to align the fan modules with the wind's direction and speed, and a designed rope guide system that allowed the flag to be raised and lowered smoothly through the modules. Integrating the above concepts—lifting fans, the swivel mechanism, and the flag-raising and lowering systems—into a custom-made flag mast measuring 110 feet enabled the flag to fly majestically despite periods of low wind speed. Today, the module stands ready to showcase the grandeur of any flag in the absence of natural wind at the ELGi Air Center Plant in Coimbatore, Tamil Nadu.

Dr. Jairam Varadaraj, Managing Director, Elgi Equipments Limited, commented, "ELGi remains committed to finding innovative solutions to complex challenges. Technology is the cornerstone for our engineering products as we strive towards consistently delivering customer satisfaction through multiple initiatives that help us define ourselves as disruptors and not followers of global industry standards. Project Tiranga was no easy task, and there were several hindrances along the way. Nevertheless, in line with our culture of innovation and long-term thinking, we collaboratively drew on our knowledge and experience in compressed air systems to go above and beyond and contribute to a matter of national pride."

For over 60 years, ELGi's pioneering products and compressed air solutions have served various applications across industries ranging from manufacturing to food and beverage, construction, pharmaceuticals, and textiles in over 120 countries. Powering a 400+ product-strong portfolio, ELGi's state-of-the-art global manufacturing facilities, spanning three continents, are committed to carbon neutrality, water conservation, and circular waste management.

Eminent Personalities Win Awards By Academy of General Education, MEMG, Manipal Media Network And Dr. TMA Pai Foundation

Academy of General Education, Manipal Academy of Higher Education, MEMG, Manipal Media Network Ltd and Dr. TMA Pai Foundation, Manipal conducted “New Year Awards 2024” to honour eminent personalities of Udupi & Dakshin Kannada districts for their immense contributions to society, art and culture. The awards were conferred to five achievers who have contributed in their own ways in culture, literature and have even created awareness in this unprecedented situation.  The welcome address was made by Dr H S Ballal - Pro Chancellor & President, Academy of General Education, MAHE and the felicitation address was given by Lt Gen (Dr.) M D Venkatesh - Vice Chancellor, MAHE.

The winners of this year were: Dr M Narendra, an esteemed Senior Professional and Retired Chairman and Managing Director of Indian Overseas Bank; Dr Jaimala Ramachandra, Cine Artist and Producer; Dr H Manjunatha Hande, Professor, HOD and Unit Head in the Department of Medicine, Kasturba Medical College, Manipal; Dr Yadkathody Sanjeeva Rai, former Dean of Kasturba Medical College, Mangalore, and a distinguished Cosmetic Surgeon at Kasturba Medical College, Mangalore and Sri. B. K. Deva Rao Agriculturist.

Commenting on the occasion, Dr H S Ballal - Pro Chancellor, MAHE said, “Being the hosts of this wonderful celebration of the contributions and outstanding accomplishments of the five recipients is an honour for us. I congratulate each one of them from the bottom of my heart for their spirit. The educational system in place now looks for fresh perspectives and investigations. The liberal arts and humanities ought to be given more importance. we are thrilled to acknowledge their hard work and accomplishments in their respective fields which has added significant impact towards the betterment of the society.

Lt Gen (Dr) M D Venkatesh, Vice Chancellor, MAHE sharing his excitement said, “We are exuberant to felicitate the outstanding achievements of the new year awardees, and this is undoubtedly a terrific occasion for us. We value their unparalleled contributions to literature, agriculture, medicine, culture, and mankind. They have gone above and beyond the call of duty to establish an example for others to follow and instil virtues in the community. The most effective way to address societal issues or raise awareness is through these literary and artistic disciplines. Honouring the achievers serves a dual purpose: it not only shows appreciation and recognition for their hard work, but it also serves as a springboard for young people to aim higher”.

Humbled by the award, Dr M. Narendra conveyed, “With deep appreciation I extend my sincere gratitude to the community for choosing me. This serves as not just a personal achievement but a celebration of the vital role of banking in shaping our economic landscape. From early on, I have been committed to contribute to the welfare of society through the financial sector by fostering economic growth, and financial inclusion.  In a world where economic well-being is integral to the fabric of society, this award reinforces my determination to contribute to building a more inclusive and thriving society through responsible and impactful financial practices. Thank you for acknowledging my efforts and encouraging me to make a lasting positive difference”.

Expressing his happiness after receiving the award, Dr Yadkathody Sanjeeva Rai, said, “I’m grateful for this award for recognizing the path I have chosen in medicine and surgery. Receiving this award not only celebrates my individual achievements but underscores the collective effort of all those who have been integral to my professional journey especially during the establishment of Manipal College of Medical Sciences in Pokhara, Nepal. It highlights the significance of collaboration in the global healthcare landscape, and I am inspired to continue fostering partnerships that transcend borders for the betterment of medical education and healthcare.

Conveying her joy, Dr Jaimala Ramachandra said, “In this moment of reflection and gratitude, I am truly touched by the recognition given to me by the New Year Awards Committee. This recognition holds a special place in my heart, acknowledging not just my contributions to the film industry but also my commitment to public service, literature and social wellbeing.  Movies are a powerful storytelling form which can showcase the reality of society in an open forum. I see this award that reaffirms the belief in the transformative impact of cinema to connect, inspire and bring about positive change. I am deeply thankful for the encouragement to persist in my endeavours.”

Honoured by the recognition, Dr H Manjunatha Hande, “I extend my heartfelt appreciation for recognizing my journey dedicated to medical education and research. It serves as a powerful acknowledgement of the importance of medicine in shaping a healthier and brighter future for our communities.”

Overcome with joy, Sri. B. K. Deva Rao Agriculturist, “With sincere gratitude, I am humbled with the recognition given to me through the award. This acknowledgement reflects the tireless efforts of every farmer into cultivating our lands. I thank the community for considering me and celebrating the vital role of agriculture in our community.”

The event was aptly concluded with a heartfelt vote of thanks by Dr Raviraj N S, Director, Planning & Monitoring, acknowledging the enthusiastic participation and support of the entire community.

Kotak Mahindra Bank Standalone PAT For 9MFY24 Rs 9,648 Crore, Up 30% YoY

* Q3FY24 Rs 3,005 Crore, Up 8% YoY

* Consolidated PAT for 9MFY24 Rs 12,876 crore, up 24% YoY

* Q3FY24 Rs 4,265 crore, up 7% YoY

The Board of Directors of Kotak Mahindra Bank (“the Bank”) approved the unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2023, at the Board meeting held in Mumbai, today.

Kotak Mahindra Bank standalone results

The Bank’s PAT for 9MFY24 increased to Rs 9,648 crore from Rs 7,444 crore in 9MFY23, up 30% YoY. PAT for Q3FY24 stood at Rs 3,005 crore, up 8% YoY from Rs 2,792 crore in Q3FY23.  Q3FY24 results for the Bank include Rs143 cr provision (post tax) on applicable Alternate Investment Fund (AIF) investments pursuant to RBI’s circular dated December 19, 2023.

Net Interest Income (NII) for 9MFY24 increased to Rs 19,084 crore, from Rs 15,449 crore in 9MFY23, up 24% YoY and for Q3FY24 increased to Rs 6,554 crore, from Rs 5,653 crore in Q3FY23, up 16% YoY. Net Interest Margin (NIM) was 5.22% for Q3FY24.

Fees and services for 9MFY24 increased to Rs 5,998 crore from Rs 4,861 crore in 9MFY23, up 23% YoY and for Q3FY24 increased to Rs 2,144 crore from Rs 1,695 crore in Q3FY23, up 26% YoY.

Operating profit for 9MFY24 increased to Rs 14,126 crore from Rs 10,201 crore, up 38% YoY and for Q3FY24 was Rs 4,566 crore, up 19% YoY (Q3FY23: Rs 3,850 crore).

Customers as at December 31, 2023 were 4.8 cr (3.9 cr as at December 31, 2022).

Advances (incl. IBPC & BRDS) increased 19% YoY to Rs 3,72,464 crore as at December 31, 2023 from

Rs 3,13,154 crore as at December 31, 2022. Customer Assets, which comprises Advances (incl. IBPC & BRDS) and Credit Substitutes, increased by 17% YoY to Rs 4,00,759 crore as at December 31, 2023 from RS 3,41,733 crore as at December 31, 2022.

Unsecured retail advances (incl. Retail Micro Finance) as a % of net advances stood at 11.6% as at December 31, 2023. (9.3% as at December 31, 2022).

CASA ratio as at December 31, 2023 stood at 47.7%.

Average Current deposits grew to RS 59,337 crore for Q3FY24 compared to RS 56,372 crore for Q3FY23 up 5% YoY. Average Savings deposits grew to RS 1,23,227 crore for Q3FY24 compared to ? 1,18,442 crore for Q3FY23 up 4% YoY . Average Term deposit up 43% YoY from RS 1,51,470 crore for Q3FY23 to RS 2,16,344 crore for Q3FY24.

ActivMoney was launched in Q1FY24 and TD sweep balance grew 13% QoQ (non-annualised) to RS 41,784 crore.

As at December 31, 2023, GNPA was 1.73% & NNPA was 0.34% (GNPA was 1.90% & NNPA was 0.43% at December 31, 2022). The provision coverage ratio stood at 80.6%.

Capital Adequacy Ratio of the Bank, as per Basel III, as at December 31, 2023 was 21.2% and CET I ratio of 20.1% (both including unaudited profits).

Consolidated results at a glance

Consolidated PAT for 9MFY24 increased to RS12,876 crore from RS 10,359 crore in 9MFY23, up 24% YoY and for Q3FY24 was Rs 4,265 crore, up 7% YoY from Rs 3,995 crore in Q3FY23. Rs 12,876 crore from Rs10,359 crore in 9MFY23, up 24% YoY and for Q3FY24 was Rs 4,265 crore, up 7% YoY from Rs 3,995 crore in Q3FY23.

*Q3FY24 results for the Bank include Rs143 cr provision (post tax) on applicable Alternate Investment Fund (AIF) investments pursuant to RBI’s circular dated December 19, 2023.

At the consolidated level, the Return on Assets (ROA) for Q3FY24 (annualized) was 2.46% (2.76% for Q3FY23). Return on Equity (ROE) for Q3FY24 (annualized) was 13.83% (15.04% for Q3FY23).

Consolidated Capital Adequacy Ratio as per Basel III as at December 31, 2023 was 22.2% and CET I ratio was 21.2% (both including unaudited profits).

Consolidated Capital and Reserves & Surplus as at December 31, 2023 was Rs 1,25,039 crore (Rs 1,07,670 crore as at December 31, 2022). The Book Value per Share was Rs 627.

Consolidated Customer Assets which comprises Advances (incl. IBPC & BRDS) and Credit Substitutes grew by 19% YoY from Rs 3,79,820 crore as at December 31, 2022 to Rs 4,51,524 crore as at December 31, 2023.

Total assets managed / advised by the Group as at December 31, 2023 were Rs 5,33,365 crore up 32% YoY over Rs 4,05,269 crore as at December 31, 2022. The Domestic MF Equity AUM increased by 44% YoY to Rs 2,29,168 crore as at December 31, 2023.

The financial statements of Indian subsidiaries (excluding insurance companies) and associates are prepared as per Indian Accounting Standards in accordance with the Companies (Indian Accounting Standards) Rules, 2015. The financial statements of subsidiaries located outside India are prepared in accordance with accounting principles generally accepted in their respective countries. However, for the purpose of preparation of the consolidated financial results, the results of subsidiaries and associates are in accordance with Generally Accepted Accounting Principles in India (‘GAAP’) specified under Section 133 and relevant provision of Companies Act, 2013.

About Kotak Mahindra Group

Established in 1985, Kotak Mahindra Group is one of India's leading financial services conglomerates. In February 2003, Kotak Mahindra Finance Ltd. (KMFL), the Group's flagship company, received banking license from the Reserve Bank of India (RBI), becoming the first non-banking finance company in India to convert into a bank - Kotak Mahindra Bank Ltd (KMBL).

Kotak Mahindra Group (Group) offers a wide range of financial services that encompass every sphere of life. From commercial banking, to stock broking, mutual funds, life and general insurance and investment banking, the Group caters to the diverse financial needs of individuals and the corporate sector. The premise of Kotak Mahindra Group’s business model is concentrated India, diversified financial services. The bold vision that underscores the Group’s growth is an inclusive one, with a host of products and services designed to address the needs of the unbanked and insufficiently banked.

Kotak Mahindra Group has a global presence through its subsidiaries in UK, USA, Gulf Region, Singapore and Mauritius with offices in London, New York, Dubai, Abu Dhabi, Singapore and Mauritius respectively. As on 31st December, 2023, Kotak Mahindra Bank Ltd has a national footprint of 1,869 branches and 3,239 ATMs, and branches in GIFT City and DIFC (Dubai).

For more information, please visit the Company’s website at https://www.kotak.com

CEAT Launches Steel Rad Tyres For High Powered Motorcycles In Two Variants - SPORTRAD And CROSSRAD

·         New Steel Radial Motorcycle tyres will offer new levels of handling and grip on all terrains

·         Signs up Geoffrey Emmanuel as its first brand ambassador in racing as CEAT forays into the world of motorsports

CEAT, a leading tyre manufacturer, has taken the performance of its two-wheeler tyre range to a higher level with a new range of steel radial tyres, SPORTRAD and CROSSRAD. This premium range of steel radial tyres is specially crafted to unleash the full potential of high performance motorcycles. The SPORTRAD series is designed for high speed and cornering; while the CROSSRAD is a multi terrain high grip tyre.Steel Rad tyres feature a steel-belted radial construction, providing superior handling at high speeds.

The CROSSRAD series is compatible with motorcycles such as Yamaha FZ Series and Suzuki Gixxer Series and priced at INR: 4,300 for the set of tyres.

The SPORTRAD series is compatible with High performance motorcycles such as KTM RC390, Duke 390 Bajaj Dominar 400, TVS Apache RR310 and is priced at INR: 12,500 for the set of tyres.

The SPORTRAD platform is equipped with equidistant midcrown grooves for enhanced cornering stability, and a silica-blended tread compound for a perfect balance of stiffness. These tyres deliver a sporty performance that exceeds expectations. Incorporating advanced features like slick shoulders for extreme lean angles, an optimized groove design for superior wet grip and cornering stability, and a maximized slick area at the crown for stability at speeds up to 270 kmph, the SPORTRAD series ensures an unparalleled riding experience.

The CROSSRAD platform features an asymmetrical block tread design and transversal grooves placed along the circumference of the tyre which combine to provide superior grip in gravel/mud and other off-road terrains. Additionally, the interconnected shoulder blocks offer a wider contact area for an enhanced cornering grip. With the uniquely shaped centre blocks and a steel-belted radial construction, the CROSSRAD series offers a much superior handling experience for offroad enthusiasts.

Mr. Arnab Banerjee, MD & CEO, CEAT, commented, “Steel Rad series is a testament to CEAT's commitment to innovation and quality. With the Steel Rad series, we are introducing a new era of motorcycle tyres that combine cutting-edge technology with a passion for performance. We understand the unique needs of riders with high-performance bikes, and these tyres are designed to meet and exceed their expectations. From extreme lean angles to high-speed stability, every aspect has been meticulously crafted to enhance the riding experience."

Mr. Lakshmi Narayanan B., Chief Marketing Officer, CEAT, said, "At CEAT, we understand the passion for precision performance. This is our answer to riders who demand the best from their machines. These tyres are about delivering tangible results on the road. The steel radial construction offers rock-solid stability and responsive handling. Whether it’s for track days, weekend getaways, or your daily commute, these tyres ensure performance and unparalleled reliability on the road."

CEAT Steel Rad tyres are meticulously designed for the performance segment of motorcycles. The road-biased SPORTRAD platform, with an 80:20 on-off road bias, will be initially launched in two sizes: 110/70ZR17 and 150/60ZR17. The CROSSRAD platform, with a 60/40 ON-OFF split, currently offers one size - 140/60R17.

CEAT invites riders, enthusiasts, and industry professionals to explore the Steel Rad series, now available at authorized CEAT dealerships across India.

Brand Ambassador Announcement:

In a monumental move into the world of motorsports, CEAT proudly announces Geoffrey Emmanuel as its first brand ambassador in racing. Geoffrey, the first Indian rider to compete in the FIM Junior World Championship riding in MOTO3, is working towards participating in the MotoGP World Championship starting from India MotoGP Bharat in September 2024. His journey signifies CEAT's commitment to supporting and endorsing exceptional talent in the world of motorcycle racing.

About CEAT Ltd (www.ceat.com):

CEAT, the flagship company of RPG Enterprises, was established in 1958. Today, CEAT is one of India’s leading tyre manufacturers and has a strong presence in global markets. CEAT produces more than 41 million high-performance tyres, catering to various segments like 2-3 Wheelers, Passenger and Utility Vehicles, Commercial Vehicles and Off-Highway Vehicles.

About RPG Group (www.rpggroup.com):

RPG Group, established in 1979, is one of India’s fastest-growing business groups with a turnover of US$ 4.4 Billion. The group has diverse business interests in the areas of Infrastructure, Tyres, Pharma, IT and Specialty as well as in emerging innovation-led technology businesses.

Indian Immunologicals Ltd (IIL) Rolls Out India’s First Indigenously Developed Hepatitis A Vaccine “Havisure®”

* India Achieves Self-Sufficiency For Hepatitis A Vaccine, True Example Of Atma Nirbhar Bharat

Indian Immunologicals Ltd (IIL) a wholly owned subsidiary of National Dairy Development Board (NDDB) and a leading biopharmaceutical company in India marks a historic moment in public health with the launch of India’s first indigenously developed Hepatitis A vaccine “Havisure®”. The vaccine represents a significant step forward in India's fight against Hepatitis A and is poised to make a substantial contribution to public health. 

The new vaccine, Havisure®is the result of extensive research and development efforts by IIL's dedicated team of scientists and researchers. This indigenously developed vaccine is poised to play a crucial role in preventing Hepatitis A, a highly contagious liver infection that poses a significant public health challenge. Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water. 

This Novel Vaccine launch event was held today at Hyatt Place, Hyderabad. Chief guests were Shri Nagaraj Karpan, MLA and Shri Ajay Mishra, IAS-Chairman Indian Redcross Society, Telangana. 

Speaking on the occasion, Dr. K Anand Kumar, Managing Director, Indian Immunologicals Ltd shared "The launch of Havisure® is a testament to our commitment to advancing healthcare solutions for the nation. Currently Hepatitis A vaccines are imported into our country and as a true meaning of Atma Nirbhar Bharat, IIL has tirelessly put in efforts and developed India’s 1st vaccine for Hepatitis A. The vaccine Havisure® has undergone extensive clinical trials in 8 centers and has proven to be safe and efficacious. The vaccine is comparable to the world’s leading vaccine sold by a multinational. With Havisure®, we aim to contribute significantly to the prevention of this infectious disease. IIL launching three vaccines in a single year is itself a big achievement and full credit to my team.” 

“Havisure” is set to play a crucial role to protect against the Hepatitis A virus, which primarily affects the liver. The vaccine is effective in preventing the disease and is recommended for children in the routine immunization. It is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination. 

Discussing on manufacturing capabilities of IIL, Dr. Priyabrata Pattnaik, Dy. Managing Director-IIL said, “The company has considerably invested in state-of-the-art manufacturing facilities to scale up production and meet the growing demand for Hepatitis A vaccine. As part of the launch, IIL will be collaborating with healthcare professionals, corporate hospitals, and government agencies to promote awareness about Hepatitis A and the importance of both paediatric, adolescent & adult vaccination”. 

About Indian Immunologicals Limited (IIL): 

Indian Immunologicals Limited (IIL), a wholly owned subsidiary of National Dairy Development Board (NDDB) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. For more information on IIL, visit www.indimmune.com.